Immulink MBG Received FDA-Notified GRAS Status


Super Beta Glucan Inc. Receives FDA Generally Recognized As Safe (GRAS) Status for Immulink MBG®(Mushroom Beta Glucan). SBG Receives “No Objection” Letter from the FDA; Immulink MBG® is First beta glucan derived from mushrooms to Receive GRAS Status

IRVINE, California (August 11, 2012) –Super Beta Glucan, a recognized world leader in the manufacturing and marketing of mushroom beta glucan, has received U.S. Food and Drug Administration (FDA) Generally Recognized As Safe (GRAS) status for Immulink MBG® (Mushroom Beta Glucan), a carbohydrate polymer derived from Ganoderma lucidum . Immulink MBG is the first mushroom extract to receive GRAS status; SBG spent the last five years researching, developing and implementing trials to prepare for the full GRAS filing.

The Department of Health and Human Services of the FDA has contacted Super Beta Glucan Inc. regarding GRAS Notice No. 000413 to inform the company that, based on the information provided by Super Beta Glucan Inc, as well as other information available to the FDA, the agency has no questions or objections at this time regarding the expert panel conclusion that Mushroom Beta Glucan is GRAS under the intended conditions of use.

Immulink MBG, primarily comprised of mushroom beta glucan is intended for use as a food ingredient in a variety of products including baked goods and baking mixes, beverages and beverage bases, cereal and cereal products, dairy product analogs, milk and milk products, plant protein products, processed fruits and fruit juices, soft candy, and soup and soup mixes.

“Aside from FDA’s stamp of approval, what really distinguished the Immulink MBG from pulverized mushroom powders and mushroom extracts is the proprietary extraction and purification process that is capable of removing all the impurities from the mushrooms.” , commented by SBG’s Vice President, Dr. William Wang. “For the best interest of the consumers, we wish to become a pioneer in establishing a standard where the developments of mushroom related products are based on the FDA GRAS approval.”

FDA GRAS status is recognized in many countries outside the U.S. and potentially contributes towards regulatory acceptance abroad.

Considering its properties, mushroom beta glucan is an incredible and now well-documented ingredient that’s delivering real solutions to people.” SBG’s original founder, Dr. S.N. Chen states. “We’re thrilled to provide this sort of health and wellness innovation to people worldwide and through so many affordable products that address countless customer needs and demands. Beta glucan is not only a breakthrough in medicine and pharma, but for all of us in the health and wellness field.

Immulink MBG, direct from SBG, is available to manufacturers.

About Super Beta Glucan Inc.

Headquartered in Irvine, Calif., Super Beta Glucan (SBG) Inc. is a beta glucan manufacturer and global leader in bringing the benefits of mushroom beta glucan to people throughout the world. While medicinal mushrooms have historically been used for traditional medicine, they are now documented to support the immune system and overall wellness. With the most stringent quality control and state-of-the-art equipment, SBG utilizes its proprietary biotechnology to ensure both purity and potency, providing superior, standardized mushroom beta glucan, tailored to customers’ specific needs. The beta glucan offered by SBG is GRAS certified by the FDA and is both water soluble and heat resistant, making it unlike any other beta glucan on the market.

For more information about SBG’s products and licensing opportunities, visit


William Wang, Ph.D., Vice President of Research and Development



Tags: ,